Author details

Full Name

Laure Dossus

Affiliation

ORCID

Career Start Year

2004

Papers

264

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
38079601	International Pooled Analysis of Leisure-Time Physical Activity and Premenopausal Breast Cancer in Women From 19 Cohorts.	J Clin Oncol	2024
37804448	Dietary amino acids and risk of stroke subtypes: a prospective analysis of 356,000 participants in seven European countries.	Eur J Nutr	2024
37096432	Metabolically defined body size and body shape phenotypes and risk of postmenopausal breast cancer in the European Prospective Investigation into Cancer and Nutrition.		2023
36346115	Antiplatelet drugs and breast cancer risk in a large nationwide Danish case-control study.	International Journal of Cancer	2023
36148781	Protein and amino acid intakes in relation to prostate cancer risk and mortality-A prospective study in the European Prospective Investigation into Cancer and Nutrition.	Cancer Med	2023
36053839	Baseline and lifetime alcohol consumption and risk of skin cancer in the European Prospective Investigation into Cancer and Nutrition cohort (EPIC).	International Journal of Cancer	2023
37923090	Prediagnostic selenium status, selenoprotein gene variants and association with breast cancer risk in a European cohort study.		2023
37923090	Prediagnostic selenium status, selenoprotein gene variants and association with breast cancer risk in a European cohort study.		2023
37993940	Body mass index and cancer risk among adults with and without cardiometabolic diseases: evidence from the EPIC and UK Biobank prospective cohort studies.		2023
36593337	Circulating vitamin D and breast cancer risk: an international pooling project of 17 cohorts.	Eur J Epidemiol	2023
37337133	A body shape index (ABSI) is associated inversely with post-menopausal progesterone-receptor-negative breast cancer risk in a large European cohort.		2023
37271707	Associations between dietary inflammatory scores and biomarkers of inflammation in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort.		2023
36809347	Use of menopausal hormone therapy and ovarian cancer risk in a French cohort study.		2023
37451831	Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel.	J Med Genet	2023
37250804	Genetically proxied impaired GIPR signaling and risk of 6 cancers.	iScience	2023
36797668	Dietary fatty acids and endometrial cancer risk within the European Prospective Investigation into Cancer and Nutrition.	BMC Cancer	2023
36737658	Dietary patterns related to biological mechanisms and survival after breast cancer diagnosis: results from a cohort study.		2023
37365585	Association of Mediterranean diet with survival after breast cancer diagnosis in women from nine European countries: results from the EPIC cohort study.		2023
36460776	Body shape phenotypes of multiple anthropometric traits and cancer risk: a multi-national cohort study.	British Journal of Cancer	2023
36988840	The association between body fatness and mortality among breast cancer survivors: results from a prospective cohort study.	Eur J Epidemiol	2023
37096432	Metabolically defined body size and body shape phenotypes and risk of postmenopausal breast cancer in the European Prospective Investigation into Cancer and Nutrition.		2023
34994966	Determinants of Obesity and Metabolic Health in the Afghan Population: Protocol, Methodology, and Preliminary Results.	Journal of Epidemiology and Global Health	2022
35900194	Cigarette Smoking and Endometrial Cancer Risk: Observational and Mendelian Randomization Analyses.	Cancer Epidemiol Biomarkers Prev	2022
35889914	Nutritional Factors during and after Cancer: Impacts on Survival and Quality of Life.	Nutrients	2022
35635567	Inflammatory potential of the diet and association with risk of differentiated thyroid cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort.	European Journal of Nutrition	2022
35635567	Inflammatory potential of the diet and association with risk of differentiated thyroid cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort.	European Journal of Nutrition	2022
35437568	Metabolically Defined Body Size Phenotypes and Risk of Endometrial Cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC).	Cancer Epidemiology Biomarkers and Prevention	2022
35436960	Identifying molecular mediators of the relationship between body mass index and endometrial cancer risk: a Mendelian randomization analysis.	BMC Med	2022
35430795	Circulating inflammatory biomarkers, adipokines and breast cancer risk-a case-control study nested within the EPIC cohort.	BMC Med	2022
35418701	Genome-wide interaction analysis of menopausal hormone therapy use and breast cancer risk among 62,370 women.	Sci Rep	2022
35366005	Biomarkers of the transsulfuration pathway and risk of renal cell carcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC) study.	International Journal of Cancer	2022
36258205	Pan-cancer analysis of pre-diagnostic blood metabolite concentrations in the European Prospective Investigation into Cancer and Nutrition.	BMC Medicine	2022
36258205	Pan-cancer analysis of pre-diagnostic blood metabolite concentrations in the European Prospective Investigation into Cancer and Nutrition.	BMC Medicine	2022
35603841	Prediagnosis Leisure-Time Physical Activity and Lung Cancer Survival: A Pooled Analysis of 11 Cohorts.	JNCI Cancer Spectr	2022
36552633	Dietary Intake of 91 Individual Polyphenols and 5-Year Body Weight Change in the EPIC-PANACEA Cohort.		2022
33279777	Metabolic Signatures of Healthy Lifestyle Patterns and Colorectal Cancer Risk in a European Cohort.	Clinical Gastroenterology and Hepatology	2022
35042965	Rare germline copy number variants (CNVs) and breast cancer risk.	Commun Biol	2022
35031764	Prospective evaluation of 92 serum protein biomarkers for early detection of ovarian cancer.	Br J Cancer	2022
34999853	Long-term weight change and risk of breast cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) study.	International Journal of Epidemiology	2022
34886862	Lifestyle correlates of eight breast cancer-related metabolites: a cross-sectional study within the EPIC cohort.	BMC Medicine	2021
33531438	Antiplatelet Drug Use and Breast Cancer Risk in a Prospective Cohort of Postmenopausal Women.	Cancer Epidemiology Biomarkers and Prevention	2021
33781249	Dietary intake of trans fatty acids and breast cancer risk in 9 European countries.	BMC Med	2021
34148186	Inflammatory potential of the diet and risk of breast cancer in the European Investigation into Cancer and Nutrition (EPIC) study.	Eur J Epidemiol	2021
34146516	Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element.	Am J Hum Genet	2021
34099314	Prospective analysis of circulating metabolites and endometrial cancer risk.	Gynecol Oncol	2021
33723391	Investigation of circulating metabolites associated with breast cancer risk by untargeted metabolomics: a case-control study nested within the French E3N cohort.	British Journal of Cancer	2021
33926456	Metabolic signatures of greater body size and their associations with risk of colorectal and endometrial cancers in the European Prospective Investigation into Cancer and Nutrition.	BMC Med	2021
34340701	Use of systemic glucocorticoids and risk of breast cancer in a prospective cohort of postmenopausal women.	BMC Medicine	2021
34301304	Biomarkers of mammographic density in premenopausal women.	Breast Cancer Research	2021
33038275	Weight change in middle adulthood and risk of cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort.	Int J Cancer	2021